About Doctor
Dr. Cheryn Song is among the top urologist in Seoul, South Korea. Dr. Cheryn Song is known for treatment of prostate cancer, kidney cancer & bladder cancer.
- Dr. Cheryn Song education
-
- Master of Public Health : Johns Hopkins University
- Doctor of Medicine : University of Ulsan
- Master of Medicine : University of Ulsan
- Bachelor of Medicine : Yonsei University
- Dr. Cheryn Song professional experiences
-
- Fellow visiting investigator in Memorial Sloan Kettering Cancer Center Sidney Kimmel Center for Prostate and Urologic Cancers research , USA
- Assistant Professor, Associate Professor in UUCM AMC
- Clinical Instructor in UUCM AMC
- Visiting Fellowship in Nagoya University Hospital, Japan
- Fellowship in UUCM AMC
- Residency in UUCM AMC
Hospital
Asan Medical Centre, Seoul, South Korea
Specialization
- Prostate cancer
- Bladder cancer
- Urologic cancer
Procedures Performed
- Prostate cancer treatment
- Bladder cancer treatment
- TURBT
- PCNL
- RIRS
- ESWL
- CLT / SPCLT
- Radical nephrectomy
- Partial nephrectomy
- Radical cystectomy
- VVF / UVF repair
Research & Publications
Adaptive functional change of the contralateral kidney after partial nephrectomy. |
Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma. |
Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis. |
Comparison of Hand-Assisted Laparoscopic vs Robot-Assisted Laparoscopic vs Open Partial Nephrectomy in Patients with T1 Renal Masses. |
Comparison of postoperative pain between laparoscopic and robot-assisted partial nephrectomies for renal tumors: A propensity score matching analysis. |
Does Ureteral Catheter Insertion Decrease the Risk of Urinary Leakage After Partial Nephrectomy in Patients With Renal Cell Carcinoma? |
Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus. |
Heterogeneous oncologic outcomes according to surgical pathology in high-risk prostate cancer: implications for better risk stratification and preoperative prediction of oncologic outcomes. |
Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma. |
Obesity as a Risk Factor for Unfavorable Disease in Men with Low Risk Prostate Cancer and its Relationship with Anatomical Location of Tumor. |